Neotherix will be one of 20 emerging medical technology companies that will be showcased at the Emerging Medical Technologies Spotlight on 2 March 2011. This Life Science Intelligence (LSI) event is online, providing a convenient forum in which medical technology innovators, investors, and dealmakers can connect and collaborate. The programme will feature selected companies at different stages of development that are seeking investors, acquisition and partnerships with larger medical technology companies.
Dr Mike Raxworthy, the company's founder and Chief Executive Officer, will be presenting on Neotherix' core technology, target market and recent development work on its lead product, EktoTherix™. The presentation will also cover provide information on skin cancer as a poorly-met clinical need and the company's strategy for post-surgical repair.
See the LSI press release on Yahoo News for more details.